Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity score

Comorbidities have been demonstrated to affect progression-free survival (PFS) and overall survival (OS), although their impact in multiple myeloma (MM) patients is as yet unsettled. We (1) assessed various comorbidities, (2) compared established comorbidity indices (CIs; Charlson comorbidity index...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleber, M, Ihorst, G, Terhorst, M, Koch, B, Deschler, B, Wäsch, R, Engelhardt, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255252/
https://www.ncbi.nlm.nih.gov/pubmed/22829196
http://dx.doi.org/10.1038/bcj.2011.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255252/
https://www.ncbi.nlm.nih.gov/pubmed/22829196
http://dx.doi.org/10.1038/bcj.2011.34

Ejemplares similares